Table 2.
KEGG Pathway Summary for LECs and BECs.
| Total | z Score | |||||
| List | LEC | BEC | Array | LEC | BEC | |
| (A) LEC KEGG Pathways | ||||||
| Cell cycle | 26 | 22 | 4 | 112 | 7.98 | -0.26 |
| Pyrimidine metabolism | 13 | 10 | 3 | 90 | 3.14 | -0.35 |
| One carbon pool by folate | 4 | 3 | 1 | 16 | 2.80 | 0.45 |
| Calcium signaling pathway | 26 | 15 | 11 | 174 | 2.77 | 1.56 |
| Circadian rhythm | 3 | 3 | 0 | 18 | 2.54 | -0.87 |
| Glycosphingolipid biosynthesis-neo-lactoseries | 4 | 3 | 1 | 21 | 2.21 | 0.17 |
| Insulin signaling pathway | 2 | 1 | 1 | 134 | -2.10 | -1.97 |
| Diterpenoid biosynthesis | 1 | 1 | 0 | 4 | 2.01 | -0.41 |
| Styrene degradation | 2 | 1 | 1 | 4 | 2.01 | 2.13 |
| (B) BEC KEGG Pathways | ||||||
| Carbazole degradation | 1 | 0 | 1 | 1 | -0.21 | 4.87 |
| 2,4-Dichlorobenzoate degradation | 2 | 0 | 2 | 5 | -0.48 | 4.08 |
| Cell adhesion molecules | 19 | 5 | 14 | 127 | -0.26 | 4.06 |
| Fluorene degradation | 1 | 0 | 1 | 2 | -0.30 | 3.30 |
| Histidine metabolism | 6 | 1 | 5 | 38 | -0.53 | 2.86 |
| Glycosaminoglycan degradation | 4 | 1 | 3 | 17 | 0.30 | 2.85 |
| Parkinson's disease | 4 | 1 | 3 | 18 | 0.24 | 2.72 |
| Glycan structures-degradation | 5 | 1 | 4 | 29 | -0.25 | 2.67 |
| 1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane degradation | 1 | 0 | 1 | 3 | -0.37 | 2.58 |
| Oxidative phosphorylation | 1 | 1 | 0 | 121 | -1.95 | -2.29 |
| Styrene degradation | 2 | 1 | 1 | 4 | 2.01 | 2.13 |
| Prion disease | 3 | 1 | 2 | 13 | 0.58 | 2.08 |